Invention Grant
- Patent Title: Cabazitaxel-platinum nanoparticles and methods of using same
- Patent Title (中): 卡马西他铂铂纳米颗粒及其使用方法
-
Application No.: US14216127Application Date: 2014-03-17
-
Publication No.: US09480657B2Publication Date: 2016-11-01
- Inventor: Mark T. Bilodeau , Craig A. Dunbar , Timothy E. Barder , Edward R. Lee , Rossitza G. Alargova , Danielle N. Rockwood
- Applicant: TARVEDA THERAPEUTICS, INC.
- Applicant Address: US MA Watertown
- Assignee: Tarveda Therapeutics, Inc.
- Current Assignee: Tarveda Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Agency: DT Ward, PC
- Agent Donna T. Ward; Heng Zhu
- Main IPC: A61K47/48
- IPC: A61K47/48 ; A61K9/51 ; A61K31/337 ; A61K33/24
Abstract:
The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the composition comprises a platinum compound having a heterocycle ligand. Cabazitaxel-platinum nanoparticles are disclosed herein, as well as methods of making and using the same.
Public/Granted literature
- US20140378427A1 CABAZITAXEL-PLATINUM NANOPARTICLES AND METHODS OF USING SAME Public/Granted day:2014-12-25
Information query
